van Duijnhoven, Fränzel J BBueno-De-Mesquita, H BasCalligaro, MiriamJenab, MazdaPischon, TobiasJansen, Eugène H J MFrohlich, JiriAyyobi, AmirOvervad, KimToft-Petersen, Anne PernilleTjønneland, AnneHansen, LouiseBoutron-Ruault, Marie-ChristineClavel-Chapelon, FrançoiseCottet, VanessaPalli, DomenicoTagliabue, GiovannaPanico, SalvatoreTumino, RosarioVineis, PaoloKaaks, RudolfTeucher, BirgitBoeing, HeinerDrogan, DagmarTrichopoulou, AntoniaLagiou, PagonaDilis, VardisPeeters, Petra H MSiersema, Peter DRodríguez, LaudinaGonzález, Carlos AMolina-Montes, EstherDorronsoro, MirenTormo, Maria-JoseBarricarte, AurelioPalmqvist, RichardHallmans, GöranKhaw, Kay-TeeTsilidis, Kostas KCrowe, Francesca LChajes, VeroniqueFedirko, VeronikaRinaldi, SabinaNorat, TeresaRiboli, Elio2011-12-132011-12-132011-03-07van Duijnhoven FJ, Bueno-De-Mesquita HB, Calligaro M, Jenab M, Pischon T, Jansen EH, Frohlich J, et al. Blood lipid and lipoprotein concentrations and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition. Gut. 2011 Aug;60(8):1094-1020017-5749http://hdl.handle.net/10668/246Objective To examine the association between serum concentrations of total cholesterol, high density lipoprotein cholesterol (HDL), low density lipoprotein cholesterol, triglycerides, apolipoprotein A-I (apoA), apolipoprotein B and the incidence of colorectal cancer (CRC). Design Nested case–control study. Setting The study was conducted within the European Prospective Investigation into Cancer and Nutrition (EPIC), a cohort of more than 520 000 participants from 10 western European countries. Participants 1238 cases of incident CRC, which developed after enrolment into the cohort, were matched with 1238 controls for age, sex, centre, follow-up time, time of blood collection and fasting status. Main outcome measures Serum concentrations were quantitatively determined by colorimetric and turbidimetric methods. Dietary and lifestyle data were obtained from questionnaires. Conditional logistic regression models were used to estimate incidence rate ratios (RRs) and 95% CIs which were adjusted for height, weight, smoking habits, physical activity, education, consumption of fruit, vegetables, meat, fish, alcohol, fibre and energy. Results After adjustments, the concentrations of HDL and apoA were inversely associated with the risk of colon cancer (RR for 1 SD increase of 16.6 mg/dl in HDL and 32.0 mg/dl in apoA of 0.78 (95% CI 0.68 to 0.89) and 0.82 (95% CI 0.72 to 0.94), respectively). No association was observed with the risk of rectal cancer. Additional adjustment for biomarkers of systemic inflammation, insulin resistance and oxidative stress or exclusion of the first 2 years of follow-up did not influence the association between HDL and risk of colon cancer. Conclusions These findings show that high concentrations of serum HDL are associated with a decreased risk of colon cancer. The mechanism behind this association needs further elucidation.enLipidsLípidosColorectal neoplasmsCáncer colorrectalNutrition SurveysEncuestas nutricionalesMedical Subject Headings::Chemicals and Drugs::Lipids::LipoproteinsMedical Subject Headings::Diseases::Neoplasms::Neoplasms by Site::Digestive System Neoplasms::Gastrointestinal Neoplasms::Intestinal Neoplasms::Colorectal NeoplasmsMedical Subject Headings::Health Care::Environment and Public Health::Public Health::Epidemiologic Methods::Data Collection::Nutrition Assessment::Nutrition SurveysMedical Subject Headings::Geographical Locations::Geographic Locations::Europeresearch article21383385open access10.1136/gut.2010.2250111468-3288